195 related articles for article (PubMed ID: 33382151)
21. Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.
Perez-Lopez R; Tunariu N; Padhani AR; Oyen WJG; Fanti S; Vargas HA; Omlin A; Morris MJ; de Bono J; Koh DM
Radiology; 2019 Aug; 292(2):273-286. PubMed ID: 31237493
[TBL] [Abstract][Full Text] [Related]
22. Modelling Study with an Interactive Model Assessing the Cost-effectiveness of
Scholte M; Barentsz JO; Sedelaar JPM; Gotthardt M; Grutters JPC; Rovers MM
Eur Urol Focus; 2020 Sep; 6(5):967-974. PubMed ID: 30826284
[TBL] [Abstract][Full Text] [Related]
23. Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
Taylor SA; Mallett S; Miles A; Beare S; Bhatnagar G; Bridgewater J; Glynne-Jones R; Goh V; Groves AM; Janes SM; Koh DM; Morris S; Morton A; Navani N; Oliver A; Padhani AR; Punwani S; Rockall AG; Halligan S
BMC Cancer; 2017 May; 17(1):299. PubMed ID: 28464835
[TBL] [Abstract][Full Text] [Related]
24. Comparison of
Van Damme J; Tombal B; Collette L; Van Nieuwenhove S; Pasoglou V; Gérard T; Jamar F; Lhommel R; Lecouvet FE
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771449
[TBL] [Abstract][Full Text] [Related]
25. [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
Pfannenberg C; Schwenzer N
Radiologe; 2015 Feb; 55(2):120-6. PubMed ID: 25589421
[TBL] [Abstract][Full Text] [Related]
26. The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trial.
Joshi A; Roberts MJ; Perera M; Williams E; Rhee H; Pryor D; Lehman M; Heathcote P; Wood S; Coucher J; Gustafson S; Miles K; Vela I
Clin Exp Metastasis; 2020 Aug; 37(4):551-560. PubMed ID: 32519046
[TBL] [Abstract][Full Text] [Related]
27. Imaging features of the evolving patterns of metastatic prostate cancer.
Curcean A; Curcean S; Rescigno P; Dafydd DA; Tree A; Reid A; Koh DM; Sohaib A; Tunariu N; Shur J
Clin Radiol; 2022 Feb; 77(2):88-95. PubMed ID: 34598790
[TBL] [Abstract][Full Text] [Related]
28. State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer.
Schiavina R; Chessa F; Borghesi M; Gaudiano C; Bianchi L; Corcioni B; Castellucci P; Ceci F; Ceravolo I; Barchetti G; Del Monte M; Campa R; Catalano C; Panebianco V; Nanni C; Fanti S; Minervini A; Porreca A; Brunocilla E
Int J Urol; 2019 Jan; 26(1):18-30. PubMed ID: 30238516
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
Dyrberg E; Larsen EL; Hendel HW; Thomsen HS
Acta Radiol; 2018 Sep; 59(9):1119-1125. PubMed ID: 29313360
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer.
Tulsyan S; Das CJ; Tripathi M; Seth A; Kumar R; Bal C
Nucl Med Commun; 2017 Dec; 38(12):1094-1102. PubMed ID: 28957842
[TBL] [Abstract][Full Text] [Related]
31. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
[TBL] [Abstract][Full Text] [Related]
32. A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
Hofman MS; Murphy DG; Williams SG; Nzenza T; Herschtal A; Lourenco RA; Bailey DL; Budd R; Hicks RJ; Francis RJ; Lawrentschuk N
BJU Int; 2018 Nov; 122(5):783-793. PubMed ID: 29726071
[TBL] [Abstract][Full Text] [Related]
33. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Hofman MS; Lawrentschuk N; Francis RJ; Tang C; Vela I; Thomas P; Rutherford N; Martin JM; Frydenberg M; Shakher R; Wong LM; Taubman K; Ting Lee S; Hsiao E; Roach P; Nottage M; Kirkwood I; Hayne D; Link E; Marusic P; Matera A; Herschtal A; Iravani A; Hicks RJ; Williams S; Murphy DG;
Lancet; 2020 Apr; 395(10231):1208-1216. PubMed ID: 32209449
[TBL] [Abstract][Full Text] [Related]
34. Clinical Translation of Positive Metastases Identified on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging in the Management of De Novo Synchronous Oligometastatic Prostate Cancer.
Connor MJ; Dubash S; Bass EJ; Tam H; Barwick T; Khoo V; Winkler M; Ahmed HU
Eur Urol Focus; 2021 Sep; 7(5):951-954. PubMed ID: 33384271
[TBL] [Abstract][Full Text] [Related]
35. Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer.
Chen R; Yang Q; Chen W; Yang Y; Cheng C; Sun Y; Lu J
World J Urol; 2021 Aug; 39(8):2937-2943. PubMed ID: 33521882
[TBL] [Abstract][Full Text] [Related]
36. Imaging the High-risk Prostate Cancer Patient: Current and Future Approaches to Staging.
Bjurlin MA; Turkbey B; Rosenkrantz AB; Gaur S; Choyke PL; Taneja SS
Urology; 2018 Jun; 116():3-12. PubMed ID: 29545055
[TBL] [Abstract][Full Text] [Related]
37. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
Catalano OA; Daye D; Signore A; Iannace C; Vangel M; Luongo A; Catalano M; Filomena M; Mansi L; Soricelli A; Salvatore M; Fuin N; Catana C; Mahmood U; Rosen BR
Int J Oncol; 2017 Jul; 51(1):281-288. PubMed ID: 28535000
[TBL] [Abstract][Full Text] [Related]
38.
Lengana T; Lawal IO; Boshomane TG; Popoola GO; Mokoala KMG; Moshokoa E; Maes A; Mokgoro NP; Van de Wiele C; Vorster M; Sathekge MM
Clin Genitourin Cancer; 2018 Oct; 16(5):392-401. PubMed ID: 30120038
[TBL] [Abstract][Full Text] [Related]
39. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT--initial clinical experience.
Squillaci E; Manenti G; Mancino S; Cicciò C; Calabria F; Danieli R; Schillaci O; Simonetti G
Abdom Imaging; 2008; 33(6):676-88. PubMed ID: 18373114
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer.
Eschmann SM; Pfannenberg AC; Rieger A; Aschoff P; Müller M; Paulsen F; Anastasiadis A; Claussen CD; Bares R; Schlemmer HP
Nuklearmedizin; 2007; 46(5):161-8; quiz N47-8. PubMed ID: 17938748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
